Provided by Tiger Trade Technology Pte. Ltd.

Labcorp Holdings Inc

322.73
-1.7800-0.55%
Post-market: 322.730.00000.00%19:43 EDT
Volume:559.88K
Turnover:180.97M
Market Cap:26.11B
PE:26.72
High:326.79
Open:326.79
Low:321.40
Close:324.51
52wk High:341.80
52wk Low:244.52
Shares:80.90M
Float Shares:80.50M
Volume Ratio:0.66
T/O Rate:0.70%
Dividend:2.88
Dividend Rate:0.89%
EPS(TTM):12.08
EPS(LYR):10.46
ROE:11.73%
ROA:5.53%
PB:3.03
PE(LYR):30.85

Loading ...

Labcorp reports Q1 adjusted EPS $4.25, consensus $4.12

TIPRANKS
·
Apr 30

Labcorp raises FY26 adjusted EPS view to $17.70-$18.35 from $17.55-$18.25

TIPRANKS
·
Apr 30

BUZZ-Labcorp rises after raising forecast, Q1 results beat estimates

Reuters
·
Apr 30

Labcorp raises full-year forecasts on steady diagnostics demand

Reuters
·
Apr 30

Stock Track | Labcorp Soars 9.80% in Pre-market on Strong Q1 Earnings Beat and Raised 2026 Guidance

Stock Track
·
Apr 30

GUIDANCE: (LH) Labcorp Expects 2026 Adjusted EPS Range $17.70 to $18.35, vs. FactSet Est of $17.86

MT Newswires Live
·
Apr 30

Labcorp FY26 Q1 adjusted EPS climbs 10.6% to $4.25; revenue rises 5.8% to $3.54 billion

Reuters
·
Apr 30

Laboratory Corp Q1 Adj. EPS $4.25 Beats $4.09 Estimate, Sales $3.538B Beat $3.505B Estimate

Benzinga Earnings
·
Apr 30

BRIEF-Labcorp Q1 Revenue USD 3,540 Million Vs. IBES Estimate USD 3,505 Million

Reuters
·
Apr 30

Labcorp Outlook FY Revenue Growth 5-6.1%

THOMSON REUTERS
·
Apr 30

Labcorp Outlook FY Adjusted EPS USD 17.7-18.35 VS. Ibes Estimate USD 17.9

THOMSON REUTERS
·
Apr 30

Labcorp Q1 Adj EPS From Cont Ops USD 4.25

THOMSON REUTERS
·
Apr 30

Corrected-Labcorp Outlook FY Labcorp Enterprise Revenue Growth (Not 'Company REV Growth') 5-6.1%

THOMSON REUTERS
·
Apr 30

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Apr 29

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Apr 24

Earning Preview: Labcorp Holdings Inc this quarter’s revenue is expected to increase by 3.16%, and institutional views are bullish

Earnings Agent
·
Apr 23

Labcorp Rolls Out Companion Diagnostic for Merck's Keytruda in Platinum-Resistant Ovarian Cancer

MT Newswires Live
·
Apr 22

Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients With Ovarian Cancer Eligible for Keytruda®

THOMSON REUTERS
·
Apr 22

Labcorp Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 22

Labcorp Holdings Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Apr 18